Epidemiologista de Harvard divulga novo estudo: cloroquina é inútil contra covid-19

Bolsonaro toma cloroquina em vídeo idiota

Eric Liang Feigl-Ding, cientista de saúde pública americano que atua no Departamento de Nutrição da Harvard, publicou um novo estudo que comprova a inutilidade da cloroquina no tratamento à covid-19.

‘Os resultados dos testes de recuperação finalmente foram lançados – e, com sorte, coloca os pregos no caixão’, afirmou, usando do ditado americano que diz respeito a uma conclusão, a um resultado definitivo.

‘Das 4700 pessoas randomizadas … A cloroquina NÃO diminuiu #covid19 mortalidade.’

Eric afirmou que além de não reduzir a taxa, a cloroquina imputou um dado negativo: a recuperação dos pacientes que a utilizaram foi mais lenta.

HYDROXYCHLOROQUINE – Recovery trial results finally out – and hopefully puts nail in coffin. Out of 4700 people randomized… HCQ did NOT lower #covid19 mortality. It anything it was trending in wrong direction. Thread ? https://t.co/6Iu0NEejON pic.twitter.com/6l85Nmz4id

— Eric Feigl-Ding (@DrEricDing) July 15, 2020

3) “Patients allocated to hydroxychloroquine were less likely 40 to be discharged from hospital alive within 28 days (60.3% vs. 62.8%; rate ratio 0.92)”. So hospital discharge is actually bad for HCQ. pic.twitter.com/z9myA4eBXV

— Eric Feigl-Ding (@DrEricDing) July 15, 2020

5) Bottomline- HCQ didn’t lower mortality. If anything, those randomized to HCQ were discharged from hospital SLOWER than usual care controls. And those randomized to HCQ were ventilated/died (composite) more quickly. No diff by age, gender, early/late, and by severity. #covid19

— Eric Feigl-Ding (@DrEricDing) July 15, 2020

7) I’ve probably looked at tens of thousands of trial reports in my life, many junk, many okay, some excellent. This RECOVERY trial rates among one of the top class trials—they also did the big dexamethasone trial. More Recovery data coming. Stay tuned. https://t.co/ac3unB5ML3

— Eric Feigl-Ding (@DrEricDing) July 15, 2020